Advertisement
Research Article| Volume 6, ISSUE 4, P198-199, April 1997

Download started.

Ok

Neuroprotection: before and after thrombolysis

  • Patrick D. Lyden
    Correspondence
    Address reprint requests to Patrick D. Lyden, MD, Department of Neuroscience, UCSD Stroke Center, OPC 3rd Floor, Suite 3, 200 W Arbor Dr, San Diego, CA 92103-8466.
    Affiliations
    UCSD Stroke Center, University of California, San Diego, CA., USA
    Search for articles by this author
DOI:https://doi.org/10.1016/S1052-3057(97)80010-9
Neuroprotection: before and after thrombolysis
Previous ArticleThrombolysis: Findings and lessons of the clinical trials
Next ArticlePresent status of the imaging of acute strokes
      This paper is only available as a PDF. To read, Please Download here.
      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      Subscribe:

      Subscribe to Journal of Stroke and Cerebrovascular Diseases
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Register: Create an account
      Institutional Access: Sign in to ScienceDirect

      References

        • The National Institute of Neurological Disorders and Stroke rt-PA Stroke Study Group
        Tissue plasminogen activator for acute ischemic stroke.
        N Engl J Med. 1995; 333: 1581-1587
        • Feldmann E
        • Gordon N
        • Brooks JM
        • Brass LM
        • Fayad PB
        • Sawaya KL
        • et al.
        Factors associated with early presentation of acute stroke.
        Stroke. 1993; 24: 1805-1810
        • Harper GD
        • Haigh RA
        • Potter JF
        • Castleden CM
        Factors delaying hospital admission after stroke in Leicestershire.
        Stroke. 1992; 23: 835-838
        • Alberts MJ
        • Perry A
        • Dawson DV
        • Bertels C
        Effects of public and professional education on reducing the delay in presentation and referral of stroke patients.
        Stroke. 1992; 23: 352-356
        • Grotta J
        The current status of neuronal protective therapy: why have all neuronal protective drugs worked in animals but none so far in stroke patients?.
        Cerebrovasc Dis. 1994; 4: 115-120
        • Lyden PD
        • Zivin JA
        Hemorrhagic transformation after cerebral ischemia: Mechanisms and incidence.
        Cerebrovasc Brain Met Rev. 1993; 5: 1-16
        • Hsu CY
        Criteria for valid preclinical trials using animal stroke models.
        Stroke. 1993; 24: 633-636
        • Pellegrini-Giampietro DE
        • Cozzi A
        • Moroni F
        The glycine antagonist and free radical scavenger 7-C1-thiokynurenate reduces CA1 ischemic damage in the gerbil.
        Neuroscience. 1994; 63: 701-709
        • Newell DW
        • Barth A
        • Malouf AT
        Glycine site NMDA receptor antagonists provide protection against ischemia-induced neuronal damage in hippocampal slice cultures.
        Brain Res. 1995; 675: 38-44
        • Lyden PD
        GABA and Neuroprotection.
        in: Green AR Cross AJ Neuroprotective agents and cerebral ischaemia. Academic, London1997: 233-258
        • Hallenbeck JM
        • Frerichs KU
        Stroke therapy. It may be time for an integrated approach.
        Arch Neurol. 1993; 50: 768-770

      Article info

      Identification

      DOI: https://doi.org/10.1016/S1052-3057(97)80010-9

      Copyright

      © 1997 National Stroke Association. All rights reserved. Published by Elsevier Inc.

      ScienceDirect

      Access this article on ScienceDirect

      The content on this site is intended for healthcare professionals.


      We use cookies to help provide and enhance our service and tailor content. To update your cookie settings, please visit the Cookie Preference Center for this site.
      Copyright © 2023 Elsevier Inc. except certain content provided by third parties.


      RELX